Cannabis Pharma Factory Discovered

The chemical pathway that Cannabis sativa uses to create bioactive compounds called cannabinoids has been discovered by researchers.

The chemical pathway that Cannabis sativa uses to create bioactive compounds called cannabinoids has been discovered by researchers. The research appears online in the July 16 early edition of the Proceedings of the National Academy of Sciences (PNAS).

U of S adjunct professor of biology Jon Page explains that the pathway is an unusual one, involving a specialized version of one enzyme, called hexanoyl-CoA synthetase, and another enzyme, called olivetolic acid cyclase (OAC), that has never before been seen in plants.

Cannabis
Cannabis has a long history of medicinal, recreational, and industrial use and comes from a bushy plant with thick sticky flowers called Cannabis Sativa

"What cannabis has done is take a rare fatty acid with a simple, six-carbon chain and use it as a building block to make something chemically complex and pharmacologically active," Page says.

Page led the research with PhD student Steve Gagne, who discovered OAC, and postdoctoral researcher Jake Stout, who discovered hexanoyl-CoA synthetase (reported earlier this year in The Plant Journal).

Source-Eurekalert

Drug Abuse Screening Test
Drug Abuse Screening Test (DAST) is a screening test to find out if you need professional help with ‘Drug Abuse’ problem. This is only an anonymous self test.

Cannabis Cannot Retard the Progression of Multiple Sclerosis
Cannabis does not help retard the progression of multiple sclerosis (MS), a recent study has revealed.

Progression of Multiple Sclerosis Not Affected by Active Ingredient of Cannabis
There is no evidence to suggest that the main active constituent of cannabis (tetrahydrocannabinol or THC) is effective in slowing the course of progressive multiple sclerosis